Fidelity International’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$30.3M	Sell	91,499 -2,665	-3%	-$907K	0.02%	427
2025 Q4	$37.4M	Sell	94,164 -41,320	-30%	-$18.3M	0.03%	389
2025 Q3	$61.8M	Sell	135,484 -12,453	-8%	-$5.07M	0.05%	308
2025 Q2	$48.2M	Buy	147,937 +30,075	+26%	+$8.32M	0.04%	346
2025 Q1	$31.8M	Buy	117,862 +95,796	+434%	+$24.6M	0.03%	384
2024 Q4	$5.19M	Buy	22,066 +7,236	+49%	+$1.9M	﹤0.01%	594
2024 Q3	$4.08M	Sell	14,830 -394	-3%	-$103K	﹤0.01%	639
2024 Q2	$3.7M	Buy	15,224 +4,869	+47%	+$769K	﹤0.01%	633
2024 Q1	$1.55M	Sell	10,355 -66,482	-87%	-$11.1M	﹤0.01%	698
2023 Q4	$14.7M	Sell	76,837 -13,131	-15%	-$2.24M	0.02%	452
2023 Q3	$15.9M	Sell	89,968 -16,470	-15%	-$3.14M	0.02%	439
2023 Q2	$20.2M	Sell	106,438 -22,373	-17%	-$4.44M	0.02%	401
2023 Q1	$25.8M	Buy	128,811 +128,807	+3,220,175%	+$27.1M	0.03%	365
2022 Q4	$951	Buy	4 +2	+100%	+$427	﹤0.01%	821
2022 Q3	$0	Buy	+2	New	+$381	﹤0.01%	831